LabTech launches MicroStreak in US
Wednesday, 11 June, 2008
Adelaide-based diagnostics company LabTech Systems (ASX: LBT) has launched its MicroStreak technology in the US.
The company held a launch for the product, which has been named PREVI Isola by licensees bioMerieux, at the American Society of Microbiology meeting held in Boston this week.
MicroStreak is a new method of microbiology processing, automating the streaking of agar plates to test samples. The technology was already launched in Europe in April.
LabTech has earned $4.9 million in licence fees to date.
For a full report on the MicroStreak, see the July/August edition of Australian Life Scientist.
Liquid fat treatment provides hope for rare childhood disease
A liquid fat supplement, triheptanoin, can reverse mitochondrial dysfunction and cell death in...
NSW Govt delivers foot-and-mouth vaccine to protect livestock
A biodegradable vaccine to protect livestock from foot-and-mouth disease has been developed as...
Scientists optimise delivery of mRNA to target cells
A highly versatile new method captures and attaches antibodies to the surface of mRNA-loaded...
